Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs oral finasteride in androgenetic alopecia
IRCT20220901055844N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of finasteride in androgenetic alopecia (AGA) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
finasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20220901055844N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220901055844N1.